Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.
Younes N, Fulton N, Tanaka R, Wayne J, Straus FH 2nd, Kaplan EL. Younes N, et al. Among authors: fulton n. Cancer. 1997 May 1;79(9):1804-8. Cancer. 1997. PMID: 9128999
DNA from the small intestine tumors was analyzed for K-ras, H-ras, and N-ras oncogene mutations at codons 12, 13, and 61, using polymerase chain reaction and sequence specific oligonucleotide hybridization techniques. ...No other K-ras, H-ras, or N-ras mutations wer …
DNA from the small intestine tumors was analyzed for K-ras, H-ras, and N-ras oncogene mutations at codons 12, 13, and 61, using polym …
N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma.
Hara H, Fulton N, Yashiro T, Ito K, DeGroot LJ, Kaplan EL. Hara H, et al. Among authors: fulton n. Surgery. 1994 Dec;116(6):1010-6. Surgery. 1994. PMID: 7985080
Patients were grouped as follows: class I, intrathyroidal disease, n = 21; class II, cervical node metastases, n = 22; class III, extrathyroidal disease, n = 19; and class IV, distant metastases, n = 29. ...CONCLUSIONS: Mutation of N-ras gene at …
Patients were grouped as follows: class I, intrathyroidal disease, n = 21; class II, cervical node metastases, n = 22; class I …
N-ras 61 oncogene mutations in Hürthle cell tumors.
Schark C, Fulton N, Jacoby RF, Westbrook CA, Straus FH 2nd, Kaplan EL. Schark C, et al. Among authors: fulton n. Surgery. 1990 Dec;108(6):994-9; discussion 999-1000. Surgery. 1990. PMID: 2247846
Analysis of N-ras sequences at codon position 61, with the polymerase chain reaction method and oligonucleotide probe hybridization, showed point mutations of the normal codon CAA* in eight tumor samples. ...These mutations would result in amino acid substitutions of lysin …
Analysis of N-ras sequences at codon position 61, with the polymerase chain reaction method and oligonucleotide probe hybridization, …
The value of measurement of ras oncogenes and nuclear DNA analysis in the diagnosis of Hürthle cell tumors of the thyroid.
Schark C, Fulton N, Yashiro T, Stanislav G, Jacoby R, Straus FH 2nd, Dytch H, Bibbo M, Kaplan EL. Schark C, et al. Among authors: fulton n. World J Surg. 1992 Jul-Aug;16(4):745-51; discussion 752. doi: 10.1007/BF02067375. World J Surg. 1992. PMID: 1413844
Mutations of H-ras, K-ras, and N-ras genes were analyzed by oligonucleotide probe hybridizations to polymerase chain reaction (PCR) amplified DNA. HCT were classified by light microscopy as benign (n = 22), intermediate (n = 30), and malignant (n = 13) …
Mutations of H-ras, K-ras, and N-ras genes were analyzed by oligonucleotide probe hybridizations to polymerase chain reaction (PCR) a …
Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors.
Yashiro T, Fulton N, Hara H, Yasuda K, Montag A, Yashiro N, Straus F 2nd, Ito K, Aiyoshi Y, Kaplan EL. Yashiro T, et al. Among authors: fulton n. Surgery. 1993 Oct;114(4):758-63; discussion 763-4. Surgery. 1993. PMID: 8211691
Fifty were K-ras mutations and one unusual tumor exhibited a N-61 ras mutation. CONCLUSIONS: Ras oncogene mutations do not play a role in the tumorigenesis of pancreatic endocrine tumors....
Fifty were K-ras mutations and one unusual tumor exhibited a N-61 ras mutation. CONCLUSIONS: Ras oncogene mutations do not play a rol …
Highly abundant genes in the transcriptosome of human and baboon CD34 antigen-positive bone marrow cells.
Gomes I, Sharma TT, Mahmud N, Kapp JD, Edassery S, Fulton N, Liang J, Hoffman R, Westbrook CA. Gomes I, et al. Among authors: fulton n. Blood. 2001 Jul 1;98(1):93-9. doi: 10.1182/blood.v98.1.93. Blood. 2001. PMID: 11418467
Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia.
Yashiro T, Hara H, Fulton NC, Obara T, Kaplan EL. Yashiro T, et al. Among authors: fulton nc. World J Surg. 1994 Jul-Aug;18(4):455-60; discussion 460-1. doi: 10.1007/BF00353735. World J Surg. 1994. PMID: 7725728
All mutations detected were adenine to guanine transitions at the second position of N-ras codon 61, resulting in a conversion from glutamine to arginine. ...These findings demonstrate that N-ras mutations at codon 61 may contribute to the genesis of both benign and …
All mutations detected were adenine to guanine transitions at the second position of N-ras codon 61, resulting in a conversion from g …
K-ras mutations in putative preneoplastic lesions in human colon.
Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL. Pretlow TP, et al. Among authors: fulton nc. J Natl Cancer Inst. 1993 Dec 15;85(24):2004-7. doi: 10.1093/jnci/85.24.2004. J Natl Cancer Inst. 1993. PMID: 8246286
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
Dama P, Tang M, Fulton N, Kline J, Liu H. Dama P, et al. Among authors: fulton n. J Immunother Cancer. 2019 Jul 10;7(1):175. doi: 10.1186/s40425-019-0611-3. J Immunother Cancer. 2019. PMID: 31291985 Free PMC article. Clinical Trial.
Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: a continuing dilemma.
Fedorak IJ, Salti G, Fulton N, Schark C, Straus FH 2nd, Kaplan EL. Fedorak IJ, et al. Among authors: fulton n. Am Surg. 1994 Jun;60(6):427-31. Am Surg. 1994. PMID: 8198334 Clinical Trial.
66 results
Jump to page
Feedback